Comprehensive Biotechnological Strategies for Podophyllotoxin Production from Plant and Microbial Sources
Planta Medica · 2025-03 · 91 (03) · 66-88
DOI: 10.1055/a-2504-3069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Planta Medica, online erschienen am 20.01.2025. Verfasst von Anviksha Anviksha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, Punjab, India. Hauptthemen laut MEDLINE: Podophyllotoxin, Biotechnology, Plants, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 200 Literaturangaben.
Abstract (Originalsprache)
Podophyllotoxin is derived from plant sources and exhibits strong anticancer activity. However, limited natural availability and environmental impacts from traditional extraction methods drive the search for alternative production approaches. This review explores diverse strategies for sustainable podophyllotoxin synthesis, including biosynthesis, semi-synthesis, and biotransformation. Biosynthetic methods involve metabolic pathway engineering in plant or microbial cells, enabling increased yields by manipulating precursor availability and gene expression. Semi-synthetic approaches modify podophyllotoxin precursors or intermediates to enhance therapeutic effects, with derivatives like etoposide and teniposide showing clinical efficacy. Biotransformation, utilising organisms such as endophytic fungi or human hepatic enzymes, enables the transformation of substrates like deoxypodophyllotoxin into podophyllotoxin or its derivatives, yielding compounds with reduced environmental impact and improved purity. The anticancer efficacy of podophyllotoxin and its derivatives stems from multiple mechanisms. These compounds disrupt cell mitosis by inhibiting microtubule assembly, impairing nucleoside transport, and blocking topoisomerase II activity, leading to DNA cleavage and cancer cell apoptosis. Podophyllotoxin and its derivatives also exhibit anti-angiogenesis and anti-metastatic effects through signalling pathway modulation. Notably, derivatives like deoxypodophyllotoxin utilise advanced delivery systems, enhancing targeted efficacy and reducing side effects. Given the varied mechanisms and growing therapeutic applications, optimising biotransformation and delivery techniques remains essential for advancing podophyllotoxin-based therapies. This comprehensive review underscores the compoundʼs potential as a robust anticancer agent and the need for continued research to maximise its production and clinical effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, Punjab, India.
Zitieren
APA
Anviksha, A., & Reddy, M. S. (2025). Comprehensive Biotechnological Strategies for Podophyllotoxin Production from Plant and Microbial Sources. Planta Medica, 91(03), 66-88. https://doi.org/10.1055/a-2504-3069
Vancouver
Anviksha A, Reddy MS. Comprehensive Biotechnological Strategies for Podophyllotoxin Production from Plant and Microbial Sources. Planta Medica. 2025;91(03):66-88. doi:10.1055/a-2504-3069
BibTeX
@article{Anviksha2025,
author = {Anviksha, Anviksha and Reddy, Mondem Sudhakara},
title = {Comprehensive Biotechnological Strategies for Podophyllotoxin Production from Plant and Microbial Sources},
journal = {Planta Medica},
year = {2025},
volume = {91},
number = {03},
pages = {66--88},
doi = {10.1055/a-2504-3069}
}
EUVIMED